Median Diagnostics Inc. (XKON:233250)
South Korea · Delayed Price · Currency is KRW 4,900.00
0.00 (0.00%)
At close: Oct 6, 2026
Median Diagnostics Market Cap
Median Diagnostics has a market cap or net worth of 8.56 billion as of October 23, 2026. It is the 43,722nd most valuable company in the world and the 2,653rd biggest in South Korea. Its market cap has decreased by 59.13% in one year.
Market Cap
8.56B
Enterprise Value
n/a
Revenue
7.86B
Global Rank
Country Rank
#2,653 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since June 26, 2017, Median Diagnostics's market cap has decreased from 22.09B to 8.56B, a decrease of -61.26%. That is a compound annual growth rate of -9.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 8.56B | -57.32% |
| Dec 30, 2025 | 20.05B | -20.83% |
| Dec 30, 2024 | 25.32B | -9.32% |
| Dec 28, 2023 | 27.93B | -44.77% |
| Dec 29, 2022 | 50.56B | -27.35% |
| Dec 30, 2021 | 69.60B | -3.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 168.02B |
| GC Medical Science | 97.05B |
| Inventera | 71.97B |
| Protia | 71.48B |
| HLB Panagene | 66.33B |
| GENINUS | 62.20B |
| Cytogen | 61.75B |
| Seoulin Bioscience | 34.86B |